England will be the first country to begin cancer treatment through injection with hundreds of patients. Reuters reported that the National Health Service (NHS) of England announced that hundreds of patients will be eligible for immunotherapy treatment with Atezolizumab. It is expected that this injection could reduce the treatment duration by about three-quarters of the current process. Patients will be treated through subcutaneous and intravenous injections. Dr. Alexander Martin, an oncology consultant at the NHS, stated that the approval of this treatment method not only makes the treatment process faster and easier for patients but also allows our medical teams to treat more patients throughout the day. According to the NHS, patients will receive Atezolizumab via intravenous injection for about thirty minutes to one hour, and it is predicted that this process could even be reduced to about seven minutes. Atezolizumab is an immunotherapy drug that can help the patient's immune system eliminate cancer cells. In this phase, the NHS states that patients with lung, breast, liver, and bladder cancer will be treated. It is anticipated that around 3,600 people will receive treatment annually in England at the start of this phase. The head of Shahid Beheshti Cancer Research Center: We are among the top ten countries in cancer growth. Approval of two new cancer drugs in the USA; Shahram Kordasti: A 'very good' news for patients. The Biden administration unveiled an advanced program for 'error-free cancer cell surgery.' Cancer Research Agency: Artificial sweeteners in diet sodas are 'probably carcinogenic.'
For the First Time in the World, Injection Approval for Cancer Treatment Issued in Britain
England has received approval to start cancer treatment through injections, making it the first country to do so. Hundreds of patients will be eligible for immunotherapy with Atezolizumab, which could significantly reduce treatment time. This development is crucial as it may improve patient care and increase the number of patients treated daily.
👥 Key Players
📰 What Happened
England has approved the use of Atezolizumab for cancer treatment through injections, making it the first country to implement this method. This new approach is expected to significantly reduce treatment time for patients with various types of cancer.
- Atezolizumab is an immunotherapy drug that helps the immune system fight cancer.
- Approximately 3,600 patients in England will receive this treatment annually.
💡 Why It Matters
📚 Background
Cancer remains a leading health challenge globally, with immunotherapy emerging as a promising treatment option. Atezolizumab represents a new approach that could transform cancer care.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%